Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Foodborne illness acquired in the United States--major pathogens.

Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM.

Emerg Infect Dis. 2011 Jan;17(1):7-15. doi: 10.3201/eid1701.P11101.

2.

First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure.

Molloy A, Nair S, Cooke FJ, Wain J, Farrington M, Lehner PJ, Torok ME.

J Clin Microbiol. 2010 Dec;48(12):4655-7. doi: 10.1128/JCM.00648-10. Epub 2010 Oct 13.

3.

Reduced azithromycin susceptibility in Shigella sonnei, United States.

Howie RL, Folster JP, Bowen A, Barzilay EJ, Whichard JM.

Microb Drug Resist. 2010 Dec;16(4):245-8. doi: 10.1089/mdr.2010.0028. Epub 2010 Jul 12.

PMID:
20624094
4.

In vitro activity of azithromycin against nontyphoidal Salmonella enterica.

Gunell M, Kotilainen P, Jalava J, Huovinen P, Siitonen A, Hakanen AJ.

Antimicrob Agents Chemother. 2010 Aug;54(8):3498-501. doi: 10.1128/AAC.01678-09. Epub 2010 May 24.

5.

Fluoroquinolone-resistant typhoid, South Africa.

Keddy KH, Smith AM, Sooka A, Ismail H, Oliver S.

Emerg Infect Dis. 2010 May;16(5):879-80. doi: 10.3201/eid1605.091917. No abstract available.

6.

Global trends in typhoid and paratyphoid Fever.

Crump JA, Mintz ED.

Clin Infect Dis. 2010 Jan 15;50(2):241-6. doi: 10.1086/649541. Review.

7.

Clinical practice. Bacterial diarrhea.

DuPont HL.

N Engl J Med. 2009 Oct 15;361(16):1560-9. doi: 10.1056/NEJMcp0904162. Review. No abstract available.

PMID:
19828533
8.

Typhoid fever in the United States, 1999-2006.

Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, Medalla F, Barzilay E, Joyce K, Barrett T, Mintz ED.

JAMA. 2009 Aug 26;302(8):859-65. doi: 10.1001/jama.2009.1229.

PMID:
19706859
9.

Identification of the aminoglycoside resistance determinants armA and rmtC among non-Typhi Salmonella isolates from humans in the United States.

Folster JP, Rickert R, Barzilay EJ, Whichard JM.

Antimicrob Agents Chemother. 2009 Oct;53(10):4563-4. doi: 10.1128/AAC.00656-09. Epub 2009 Jul 13. No abstract available.

10.

Antimicrobial resistance in typhoidal and nontyphoidal salmonellae.

Parry CM, Threlfall EJ.

Curr Opin Infect Dis. 2008 Oct;21(5):531-8. doi: 10.1097/QCO.0b013e32830f453a. Review.

PMID:
18725804
11.

Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines.

Al Naiemi N, Zwart B, Rijnsburger MC, Roosendaal R, Debets-Ossenkopp YJ, Mulder JA, Fijen CA, Maten W, Vandenbroucke-Grauls CM, Savelkoul PH.

J Clin Microbiol. 2008 Aug;46(8):2794-5. doi: 10.1128/JCM.00676-08. Epub 2008 Jun 11.

12.

Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes.

Roberts MC.

FEMS Microbiol Lett. 2008 May;282(2):147-59. doi: 10.1111/j.1574-6968.2008.01145.x. Epub 2008 Apr 9. Review.

13.

Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins.

Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, Medalla F, Jacoby GA, Barrett TJ.

Emerg Infect Dis. 2007 Nov;13(11):1681-8. doi: 10.3201/eid1311.061438.

14.

Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.

Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, Segler SD, Megginson M, Luedeman LJ, Shiferaw B, Hanna SS, Joyce KW, Mintz ED, Angulo FJ; Emerging Infections Program FoodNet and NARMS Working Groups.

Antimicrob Agents Chemother. 2008 Apr;52(4):1278-84. doi: 10.1128/AAC.01509-07. Epub 2008 Jan 22.

15.

Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants.

Nordmann P, Poirel L, Mak JK, White PA, McIver CJ, Taylor P.

Clin Infect Dis. 2008 Jan 15;46(2):324-5. doi: 10.1086/524898. No abstract available.

16.

Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003.

Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, Zimmerman MD.

Trans R Soc Trop Med Hyg. 2008 Jan;102(1):91-5. Epub 2007 Nov 26.

PMID:
18023462
17.

Setting and revising antibacterial susceptibility breakpoints.

Turnidge J, Paterson DL.

Clin Microbiol Rev. 2007 Jul;20(3):391-408, table of contents. Review.

18.

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, Tham NT, Wain J, Hien TT, Farrar JJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):819-25. Epub 2006 Dec 4.

20.

The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children.

Ojo KK, Ulep C, Van Kirk N, Luis H, Bernardo M, Leitao J, Roberts MC.

Antimicrob Agents Chemother. 2004 Sep;48(9):3451-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk